At the conclusion of this activity, participants will be able to:


1.  Identify patient who need genetic testing for VEXAS

2. Describe the pathophysiology of VEXAS

3.  Describe treatment options for patients with VEXAS

Session date: 
01/24/2023 - 8:30am to 9:30am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Miriam Friedman, M.D.